CVRX Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

03

Price $1.55

Market Cap (MRQ) $41M

P/E (TTM) -0.8

EPS (TTM) $-1.97

Revenue (TTM) $61M

ROE (TTM) -133.4%

Debt/Equity (MRQ) 2.9

52W Range $2–$11

CVRX Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

04

range

bars

Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.

About CVRx, Inc. - Common Stock Company overview from Wikipedia

05 · wikidata

Wikidata ↗

sectorHealth Care industryHealth Care employees223 countryUS

10-Year Performance Revenue, net income, margins and EPS trends

06

Revenue$57M

2020-12-31 → 2025-12-31

EPS$-2.04

2021-12-31 → 2025-12-31

Free Cash Flow$-41M

2021-12-31 → 2025-12-31

Net margin-84.9%

2021-12-31 → 2025-12-31

Valuation & Ratios 07–12

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric	CVRX	5Y avg	Peer Median	Verdict
P/E (TTM)	-0.85Y avg ≈-7.2	≈-7.2	·	·
P/S (TTM)	0.75Y avg ≈12.4	≈12.4	2.2	Fair value
P/B (MRQ)	2.15Y avg ≈4.6	≈4.6	3.8	Overvalued
EV / EBITDA	-0.35Y avg ≈-6.4	≈-6.4	·	·
Price / FCF (TTM)	-1.05Y avg ≈-9.3	≈-9.3	·	·
Price / Cash Flow (TTM)	-1.05Y avg ≈-9.5	≈-9.5	·	·
EV / Revenue	0.35Y avg ≈8.8	≈8.8	·	·
EV / FCF	-0.45Y avg ≈-7.1	≈-7.1	·	·
Price / Tangible Book	1.05Y avg ≈4.6	≈4.6	·	·

Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric	CVRX	5Y avg	Peer Median	Verdict
Gross Margin (TTM)	86.9%5Y avg ≈80.6%	≈80.6%	37.9%	Top tier
Operating Margin (TTM)	-79.5%5Y avg ≈-140.9%	≈-140.9%	-18.1%	Weak
EBITDA Margin	-90.5%5Y avg ≈-140.9%	≈-140.9%	-17.5%	Weak
Pretax Margin (TTM)	-84.9%5Y avg ≈-165.8%	≈-165.8%	-11.6%	Weak
Net Profit Margin (TTM)	-84.9%5Y avg ≈-166.1%	≈-166.1%	-50.8%	Below avg
ROA (TTM)	-49.1%5Y avg ≈-39.4%	≈-39.4%	-13.7%	Weak
ROE (TTM)	-133.4%5Y avg ≈-62.9%	≈-62.9%	-81.1%	Weak
ROIC	-57.7%5Y avg ≈-40.6%	≈-40.6%	-16.7%	Weak

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric	CVRX	5Y avg	Peer Median	Verdict
Debt / Equity (MRQ)	2.95Y avg ≈0.5	≈0.5	1.8	Above avg
Current Ratio (MRQ)	8.05Y avg ≈14.9	≈14.9	2.7	Strong liquidity
Quick Ratio	6.55Y avg ≈13.6	≈13.6	1.9	Strong liquidity
Long-Term Debt / Equity (MRQ)	2.95Y avg ≈0.5	≈0.5	2.9	In line

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric	CVRX	5Y avg	Peer Median	Verdict
Revenue YoY	10.4%5Y avg ≈60.7%	≈60.7%	·	·
Revenue CAGR 3Y	36.1%5Y avg ≈60.2%	≈60.2%	·	·
Revenue CAGR 5Y	56.4%	·	·	·

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric	CVRX	5Y avg	Peer Median	Verdict
EPS (Diluted)	$-2.045Y avg ≈$-2.57	≈$-2.57	·	·
Revenue / Share	$2.175Y avg ≈$1.86	≈$1.86	·	·
Cash Flow / Share	$-1.545Y avg ≈$-1.81	≈$-1.81	·	·
Cash / Share	$2.885Y avg ≈$4.70	≈$4.70	·	·

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric	CVRX	5Y avg	Peer Median	Verdict
Asset Turnover	0.55Y avg ≈0.3	≈0.3	0.7	Weak
Inventory Turnover	0.75Y avg ≈0.8	≈0.8	2.3	Weak
Receivables Turnover	5.75Y avg ≈6.0	≈6.0	5.8	In line
Revenue / Employee	≈$254.0K	·	·	·

value · ≈ 5Y avg · industry median · verdict relative to median

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

14

Avg Surprise 1.1%

Next Report Nov 03, 2026

Period	Report	EPS Actual	EPS Est	Surprise
June 30, 2026	Aug 3, 2026	$-0.53	$-0.53	0.90%
March 31, 2026		$-0.50	$-0.51	2.8%
Dec. 31, 2025		$-0.46	$-0.45	-2.8%
Sept. 30, 2025		$-0.49	$-0.51	4.2%
June 30, 2025		$-0.57	$-0.53	-7.5%
March 31, 2025		$-0.53	$-0.58	8.8%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

15

Income Statement 17

Metric	2025	2024	2023	2022	2021	2020
Revenue	$57M	$51M	$39M	$22M	$13M	$6M
Cost of Revenue	$8M	$8M	$6M	$5M	$4M	$1M
Gross Profit	$48M	$43M	$33M	$17M	$9M	$5M
R&D Expense	$11M	$11M	$12M	$10M	$8M	$6M
SG&A Expense	$88M	$91M	$65M	$50M	$28M	$10M
Operating Expenses	$100M	$102M	$76M	$60M	$35M	$16M
Operating Income	$-51M	$-59M	$-43M	$-43M	$-26M	$-12M
Interest Expense	·	·	$2M	$165.0K	$2M	$2M
Other Non-op	$4M	$4M	$4M	$1M	$-15M	$-40.0K
Pretax Income	$-53M	$-60M	$-41M	$-41M	$-43M	$-14M
Income Tax	$-18.0K	$55.0K	$147.0K	$109.0K	$91.0K	$85.0K
Net Income	$-53M	$-60M	$-41M	$-41M	$-43M	$-14M
EPS (Basic)	$-2.04	$-2.65	$-1.99	$-2.02	$-4.16	·
EPS (Diluted)	$-2.04	$-2.65	$-1.99	$-2.02	$-4.16	·
Shares (Basic)	26,084,709	22,596,229	20,754,375	20,532,838	10,360,054	·
Shares (Diluted)	26,084,709	22,596,229	20,754,375	20,532,838	10,360,054	·
EBITDA	$-51M	$-59M	$-43M	$-43M	$-26M	·

Balance Sheet 24

Metric	2025	2024	2023	2022	2021	2020
Cash & Equivalents	$76M	$106M	$91M	$106M	$142M	$59M
Receivables	$11M	$9M	$8M	$6M	$3M	$1M
Inventory	$12M	$12M	$11M	$7M	$4M	$3M
Prepaid Expense	$3M	$3M	$3M	$4M	$3M	$605.0K
Current Assets	$102M	$130M	$112M	$123M	$151M	$64M
PP&E (Net)	$2M	$3M	$2M	$2M	$1M	$410.0K
PP&E (Gross)	$6M	$6M	$5M	$4M	$3M	$2M
Accum. Depreciation	$4M	$3M	$3M	$2M	$2M	$2M
Other Non-current Assets	$26.0K	$27.0K	$27.0K	$27.0K	$26.0K	$26.0K
Total Assets	$105M	$133M	$115M	$125M	$153M	$65M
Accounts Payable	$4M	$3M	$2M	$2M	$510.0K	$483.0K
Accrued Liabilities	$9M	$8M	$6M	$6M	$5M	$4M
Current Liabilities	$13M	$11M	$8M	$8M	$6M	$8M
Capital Leases	$638.0K	$877.0K	$1M	$117.0K	$0	·
Other Non-current Liabilities	$2M	$1M	$1M	$805.0K	$681.0K	$777.0K
Total Liabilities	$65M	$62M	$39M	$16M	$7M	$28M
Long-term Debt	·	·	·	·	·	$19M
Total Debt	$50M	$49M	$29M	$7M	$0	·
Common Stock	$263.0K	$253.0K	$209.0K	$207.0K	$204.0K	$4.0K
Retained Earnings	$-591M	$-537M	$-477M	$-436M	$-395M	$-352M
AOCI	$-203.0K	$-206.0K	$-207.0K	$-207.0K	$-198.0K	$-190.0K
Stockholders' Equity	$39M	$71M	$76M	$109M	$146M	$-293M
Liabilities + Equity	$105M	$133M	$115M	$125M	$153M	$65M
Shares Outstanding	26,311,607	25,324,684	20,879,199	20,663,736	20,399,337	360,412

Cash Flow 11

Metric	2025	2024	2023	2022	2021	2020
Stock-based Comp	$11M	$19M	$6M	$4M	$2M	$132.0K
Operating Cash Flow	$-40M	$-39M	$-39M	$-43M	$-28M	$-16M
CapEx	$580.0K	$1M	$591.0K	$685.0K	$1M	$311.0K
Investing Cash Flow	$-580.0K	$-1M	$-591.0K	$-685.0K	$-1M	$-311.0K
Net Debt Issued	·	·	·	$0	$-21M	·
Stock Issued	$9M	$33M	$0	$0	$133M	$0
Net Stock Activity	$9M	$33M	·	$0	$133M	·
Financing Cash Flow	$11M	$56M	$24M	$7M	$112M	$50M
Net Change in Cash	$-30M	$15M	$-16M	$-36M	$83M	$33M
Free Cash Flow	$-41M	$-41M	$-40M	$-43M	$-29M	·
Levered FCF	·	·	$-41M	$-44M	$-31M	·

Profitability 8

Metric	2025	2024	2023	2022	2021	2020
Gross Margin	85.3%	83.8%	84.1%	77.8%	72.1%	·
Operating Margin	-90.5%	-116.0%	-109.7%	-189.3%	-199.2%	·
Net Margin	-94.1%	-116.9%	-104.8%	-184.4%	-330.4%	·
Pretax Margin	-94.1%	-116.8%	-104.5%	-183.9%	-329.8%	·
EBITDA Margin	-90.5%	-116.0%	-109.7%	-189.3%	-199.2%	·
ROA	-44.8%	-48.2%	-34.3%	-29.9%	-39.6%	·
ROE	-109.6%	-88.0%	-51.9%	-36.4%	-28.5%	·
ROIC	-57.7%	-49.5%	-41.1%	-36.8%	-17.8%	·

Liquidity & Solvency 5

Metric	2025	2024	2023	2022	2021	2020
Current Ratio	7.6	12.1	14.3	15.2	25.6	·
Quick Ratio	6.5	10.7	12.5	13.8	24.5	·
Debt / Equity	1.3	0.7	0.4	0.1	0.0	·
LT Debt / Equity	1.3	0.7	0.4	0.1	0.0	·
Interest Coverage	·	·	-24.0	-257.7	-11.7	·

Efficiency 3

Metric	2025	2024	2023	2022	2021	2020
Asset Turnover	0.5	0.4	0.3	0.2	0.1	·
Inventory Turnover	0.7	0.7	0.7	0.9	1.0	·
Receivables Turnover	5.7	6.1	6.0	5.6	6.8	·

Per Share 5

Metric	2025	2024	2023	2022	2021	2020
Book Value / Share	$1.49	$2.81	$3.64	$5.29	$7.16	·
Revenue / Share	$2.17	$2.27	$1.89	$1.09	·	·
Cash Flow / Share	$-1.54	$-1.73	$-1.88	$-2.08	·	·
Cash / Share	$2.88	$4.18	$4.34	$5.15	$6.96	·
EPS (TTM)	$-2.04	$-2.65	$-1.99	$-2.02	$-4.16	·

Growth Rates 3

Metric	2025	2024	2023	2022	2021	2020
Revenue YoY	10.4%	30.5%	74.9%	72.4%	115.4%	·
Revenue CAGR 3Y	36.1%	57.9%	86.6%	·	·	·
Revenue CAGR 5Y	56.4%	·	·	·	·	·

Valuation (TTM) 14

Metric	2025	2024	2023	2022	2021	2020
Revenue TTM	$57M	$51M	$39M	$22M	$13M	·
Net Income TTM	$-53M	$-60M	$-41M	$-41M	$-43M	·
Market Cap	$187M	$321M	$656M	$379M	$249M	·
Enterprise Value	$161M	$264M	$595M	$279M	$107M	·
P/E	-3.5	-4.8	-15.8	-9.1	-2.9	·
P/S	3.3	6.3	16.7	16.9	19.1	·
P/B	4.8	4.5	8.6	3.5	1.7	·
P / Tangible Book	4.8	4.5	8.6	3.5	1.7	·
P / Cash Flow	-4.7	-8.2	-16.8	-8.9	-9.0	·
P / FCF	-4.6	-7.9	-16.6	-8.7	-8.6	·
EV / EBITDA	-3.1	-4.4	-13.8	-6.6	-4.1	·
EV / FCF	-3.9	-6.5	-15.0	-6.4	-3.7	·
EV / Revenue	2.8	5.2	15.1	12.4	8.2	·
Earnings Yield	-28.7%	-20.9%	-6.3%	-11.0%	-34.0%	·

Income Statement 17

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$16M	$15M	$16M	$15M	$14M	$12M	$15M	$13M	$12M	$11M	$11M	$11M	$10M	$8M	$7M	$6M
Cost of Revenue	$2M	$2M	$2M	$2M	$2M	$2M	$3M	$2M	$2M	$2M	$2M	$2M	$2M	$1M	$2M	$1M
Gross Profit	$14M	$13M	$14M	$13M	$11M	$10M	$13M	$11M	$10M	$9M	$10M	$9M	$8M	$7M	$6M	$5M
R&D Expense	$3M	$3M	$3M	$3M	$2M	$3M	$3M	$3M	$3M	$3M	$2M	$3M	$3M	$3M	$3M	$2M
SG&A Expense	$24M	$22M	$22M	$22M	$23M	$21M	$20M	$22M	$21M	$28M	$17M	$16M	$16M	$15M	$14M	$13M
Operating Expenses	$27M	$25M	$25M	$25M	$26M	$24M	$23M	$24M	$24M	$31M	$19M	$18M	$20M	$19M	$17M	$15M
Operating Income	$-13M	$-12M	$-11M	$-12M	$-14M	$-13M	$-10M	$-13M	$-14M	$-22M	$-10M	$-10M	$-12M	$-12M	$-11M	$-10M
Interest Expense	·	·	·	·	·	·	·	·	·	$960.0K	·	$499.0K	$481.0K	$240.0K	$165.0K	$0
Other Non-op	$560.0K	$593.0K	$660.0K	$875.0K	$1M	$1M	$1M	$917.0K	$944.0K	$1M	$1M	$1M	$616.0K	$1M	$1M	$328.0K
Pretax Income	$-14M	$-13M	$-12M	$-13M	$-15M	$-14M	$-11M	$-13M	$-14M	$-22M	$-9M	$-9M	$-12M	$-11M	$-11M	$-10M
Income Tax	$3.0K	$1.0K	$-7.0K	$-3.0K	$-3.0K	$-5.0K	$-71.0K	$47.0K	$41.0K	$38.0K	$39.0K	$40.0K	$34.0K	$34.0K	$28.0K	$32.0K
Net Income	$-14M	$-13M	$-12M	$-13M	$-15M	$-14M	$-11M	$-13M	$-14M	$-22M	$-9M	$-9M	$-12M	$-11M	$-11M	$-10M
EPS (Basic)	$-0.53	$-0.50	$-0.45	$-0.49	$-0.57	$-0.53	$-0.39	$-0.57	$-0.65	$-1.04	$-0.45	$-0.43	$-0.56	$-0.55	$-0.51	$-0.48
EPS (Diluted)	$-0.53	$-0.50	$-0.45	$-0.49	$-0.57	$-0.53	$-0.39	$-0.57	$-0.65	$-1.04	$-0.45	$-0.43	$-0.56	$-0.55	$-0.51	$-0.48
Shares (Basic)	26,515,442	26,355,591	·	26,168,562	26,071,316	25,876,062	·	22,783,337	21,628,542	21,232,009	·	20,801,350	20,711,850	20,693,224	·	20,576,838
Shares (Diluted)	26,515,442	26,355,591	·	26,168,562	26,071,316	25,876,062	·	22,783,337	21,628,542	21,232,009	·	20,801,350	20,711,850	20,693,224	·	20,576,838
EBITDA	$-13M	$-12M	·	$-12M	$-14M	$-13M	·	$-13M	$-14M	$-22M	·	$-10M	$-12M	$-12M	·	$-10M

Balance Sheet 23

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$65M	$72M	$76M	$85M	$95M	$103M	$106M	$100M	$70M	$80M	$91M	$83M	$91M	$103M	$106M	$110M
Receivables	$9M	$9M	$11M	$8M	$7M	$9M	$9M	$9M	$9M	$8M	$8M	$6M	$7M	$6M	$6M	$5M
Inventory	$13M	$12M	$12M	$11M	$12M	$12M	$12M	$12M	$11M	$11M	$11M	$11M	$11M	$8M	$7M	$6M
Prepaid Expense	$2M	$3M	$3M	$3M	$2M	$3M	$3M	$3M	$2M	$3M	$3M	$3M	$4M	$3M	$4M	$3M
Current Assets	$89M	$97M	$102M	$108M	$116M	$126M	$130M	$124M	$92M	$102M	$112M	$104M	$112M	$121M	$123M	$124M
PP&E (Net)	$2M	$2M	$2M	$2M	$2M	$2M	$3M	$3M	$3M	$3M	$2M	$2M	$2M	$2M	$2M	$2M
PP&E (Gross)	$5M	$5M	$6M	$6M	$6M	$6M	$6M	$6M	$6M	$5M	$5M	$4M	$4M	$4M	$4M	$4M
Accum. Depreciation	$3M	$3M	$4M	$4M	$4M	$4M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$2M	$2M	$2M
Other Non-current Assets	$26.0K	$26.0K	$26.0K	$26.0K	$26.0K	$26.0K	$27.0K	$26.0K	$26.0K	$26.0K	$27.0K	$26.0K	$27.0K	$27.0K	$27.0K	$26.0K
Total Assets	$92M	$100M	$105M	$111M	$120M	$130M	$133M	$128M	$96M	$106M	$115M	$106M	$115M	$123M	$125M	$127M
Accounts Payable	$4M	$3M	$4M	$4M	$3M	$3M	$3M	$3M	$4M	$3M	$2M	$1M	$3M	$2M	$2M	$1M
Accrued Liabilities	$7M	$6M	$9M	$8M	$7M	$6M	$8M	$8M	$6M	$6M	$6M	$6M	$6M	$6M	$6M	$6M
Current Liabilities	$11M	$9M	$13M	$11M	$10M	$9M	$11M	$11M	$9M	$8M	$8M	$7M	$9M	$8M	$8M	$7M
Capital Leases	$448.0K	$544.0K	$638.0K	$730.0K	$819.0K	$802.0K	$877.0K	$951.0K	$1M	$1M	$1M	$916.0K	$946.0K	$59.0K	$117.0K	$175.0K
Other Non-current Liabilities	$2M	$2M	$2M	$2M	$2M	$2M	$1M	$1M	$1M	$1M	$1M	$960.0K	$885.0K	$815.0K	$805.0K	$761.0K
Total Liabilities	$72M	$71M	$65M	$63M	$62M	$60M	$62M	$62M	$41M	$40M	$39M	$24M	$25M	$23M	$16M	$8M
Total Debt	$59M	$58M	·	$49M	$49M	$49M	·	$49M	$29M	$29M	·	$14M	$14M	$14M	·	·
Common Stock	$266.0K	$264.0K	$263.0K	$262.0K	$261.0K	$261.0K	$253.0K	$242.0K	$217.0K	$216.0K	$209.0K	$208.0K	$208.0K	$207.0K	$207.0K	$206.0K
Retained Earnings	$-618M	$-604M	$-591M	$-579M	$-566M	$-551M	$-537M	$-527M	$-514M	$-500M	$-477M	$-468M	$-459M	$-448M	$-436M	$-426M
AOCI	$-204.0K	$-203.0K	$-203.0K	$-204.0K	$-203.0K	$-205.0K	$-206.0K	$-208.0K	$-210.0K	$-210.0K	$-207.0K	$-208.0K	$-187.0K	$-204.0K	$-207.0K	$-219.0K
Stockholders' Equity	$20M	$29M	$39M	$48M	$58M	$69M	$71M	$65M	$55M	$66M	$76M	$83M	$90M	$100M	$109M	$118M
Liabilities + Equity	$92M	$100M	$105M	$111M	$120M	$130M	$133M	$128M	$96M	$106M	$115M	$106M	$115M	$123M	$125M	$127M
Shares Outstanding	26,641,597	26,428,767	26,311,607	26,193,733	26,145,951	26,051,992	25,324,684	24,203,658	21,712,357	21,593,173	20,879,199	20,813,612	20,750,910	20,708,940	20,663,736	20,578,963

Cash Flow 10

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Stock-based Comp	$4M	$3M	$3M	$3M	$3M	$2M	$3M	$3M	$3M	$11M	$2M	$2M	$1M	$2M	$1M	$929.0K
Operating Cash Flow	$-9M	$-12M	$-10M	$-10M	$-8M	$-13M	$-8M	$-10M	$-10M	$-11M	$-8M	$-8M	$-13M	$-10M	$-11M	$-11M
CapEx	$112.0K	$122.0K	$68.0K	$295.0K	$103.0K	$114.0K	$52.0K	$37.0K	$355.0K	$917.0K	$169.0K	$39.0K	$143.0K	$240.0K	$79.0K	$264.0K
Investing Cash Flow	$-112.0K	$-122.0K	$-68.0K	$-295.0K	$-103.0K	$-114.0K	$-52.0K	$-37.0K	$-355.0K	$-917.0K	$-169.0K	$-39.0K	$-143.0K	$-240.0K	$-79.0K	$-264.0K
Stock Issued	$739.0K	$-43.0K	$-179.0K	$-45.0K	$0	$9M	$12M	$20M	$-1.0K	$547.0K	$0	$0	$0	$0	·	·
Net Stock Activity	·	$-43.0K	·	·	·	$9M	·	·	·	$547.0K	·	·	·	·	·	·
Financing Cash Flow	$1M	$9M	$410.0K	$103.0K	$392.0K	$10M	$14M	$40M	$472.0K	$1M	$16M	$363.0K	$473.0K	$8M	$7M	$7.0K
Net Change in Cash	$-8M	$-3M	$-9M	$-10M	$-8M	$-3M	$6M	$30M	$-10M	$-10M	$8M	$-8M	$-12M	$-3M	$-4M	$-11M
Free Cash Flow	·	$-12M	·	·	·	$-13M	·	·	·	$-12M	·	·	·	$-10M	·	·
Levered FCF	·	·	·	·	·	·	·	·	·	$-13M	·	·	·	$-11M	·	·

Profitability 8

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Gross Margin	87.4%	87.2%	·	86.8%	84.3%	83.5%	·	83.2%	83.9%	85.0%	·	83.9%	84.0%	83.4%	·	78.3%
Operating Margin	-82.9%	-82.3%	·	-83.5%	-105.8%	-108.8%	·	-97.3%	-118.3%	-206.4%	·	-90.6%	-123.7%	-152.4%	·	-163.7%
Net Margin	-89.4%	-88.8%	·	-87.6%	-108.4%	-111.5%	·	-98.0%	-118.8%	-206.0%	·	-85.7%	-122.6%	-142.6%	·	-158.9%
Pretax Margin	-89.4%	-88.8%	·	-87.6%	-108.5%	-111.5%	·	-97.6%	-118.5%	-205.7%	·	-85.4%	-122.3%	-142.1%	·	-158.4%
EBITDA Margin	-82.9%	-82.3%	·	-83.5%	-105.8%	-108.8%	·	-97.3%	-118.3%	-206.4%	·	-90.6%	-123.7%	-152.4%	·	-163.7%
ROA	-13.3%	-11.4%	·	-10.8%	-13.7%	-11.7%	·	-11.2%	-13.3%	-19.4%	·	-7.7%	-9.4%	-8.5%	·	-6.4%
ROE	-36.1%	-26.7%	·	-22.7%	-26.0%	-20.3%	·	-17.7%	-19.3%	-26.8%	·	-9.0%	-10.7%	-9.6%	·	-7.2%
ROIC	-16.6%	-13.9%	·	-12.6%	-13.4%	-11.3%	·	-11.4%	-16.6%	-23.3%	·	-9.8%	-11.3%	-10.7%	·	-8.6%

Liquidity & Solvency 5

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio	8.0	10.2	·	9.6	12.0	14.8	·	11.3	10.1	12.2	·	14.0	12.6	15.2	·	16.8
Quick Ratio	6.7	8.6	·	8.3	10.5	13.1	·	10.0	8.7	10.6	·	12.1	10.9	13.8	·	15.6
Debt / Equity	2.9	2.0	·	1.0	0.9	0.7	·	0.8	0.5	0.4	·	0.2	0.2	0.1	·	·
LT Debt / Equity	2.9	2.0	·	1.0	0.9	0.7	·	0.8	0.5	0.4	·	0.2	0.2	0.1	·	·
Interest Coverage	·	·	·	·	·	·	·	·	·	-23.2	·	-19.1	-24.4	-50.7	·	·

Efficiency 3

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover	0.1	0.1	·	0.1	0.1	0.1	·	0.1	0.1	0.1	·	0.1	0.1	0.1	·	0.0
Inventory Turnover	0.2	0.2	·	0.2	0.2	0.2	·	0.2	0.2	0.2	·	0.2	0.2	0.2	·	0.3
Receivables Turnover	1.9	1.6	·	1.7	1.7	1.4	·	1.7	1.5	1.4	·	1.8	1.8	1.6	·	1.4

Per Share 5

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Book Value / Share	$0.75	$1.10	·	$1.83	$2.22	$2.66	·	$2.69	$2.54	$3.07	·	$3.98	$4.34	$4.81	·	$5.75
Revenue / Share	$0.59	$0.56	·	$0.56	$0.52	$0.48	·	$0.59	$0.55	$0.51	·	$0.51	$0.46	$0.39	·	$0.30
Cash Flow / Share	·	$-0.46	·	·	·	$-0.49	·	·	·	$-0.51	·	·	·	$-0.50	·	·
Cash / Share	$2.42	$2.74	·	$3.25	$3.63	$3.94	·	$4.14	$3.24	$3.71	·	$3.99	$4.38	$4.99	·	$5.34
EPS (TTM)	$-1.97	$-2.01	·	$-1.98	$-2.06	$-2.14	·	$-2.71	$-2.57	$-2.48	·	$-2.05	$-2.10	$-2.08	·	$67.03

Valuation (TTM) 11

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	$61M	$59M	·	$56M	$55M	$53M	·	$47M	$44M	$42M	·	$35M	$31M	$26M	·	$19M
Net Income TTM	$-52M	$-53M	·	$-52M	$-52M	$-52M	·	$-58M	$-54M	$-52M	·	$-43M	$-43M	$-43M	·	$-41M
Market Cap	$137M	$250M	·	$211M	$154M	$319M	·	$213M	$260M	$393M	·	$316M	$320M	$193M	·	$192M
Enterprise Value	$131M	$236M	·	$176M	$108M	$265M	·	$162M	$219M	$342M	·	$247M	$244M	$104M	·	·
P/E	-2.6	-4.7	·	-4.1	-2.9	-5.7	·	-3.3	-4.7	-7.3	·	-7.4	-7.4	-4.5	·	0.1
P/S	2.2	4.2	·	3.8	2.8	6.0	·	4.5	5.9	9.3	·	9.0	10.4	7.3	·	10.1
P/B	6.9	8.6	·	4.4	2.7	4.6	·	3.3	4.7	5.9	·	3.8	3.6	1.9	·	1.6
P / Tangible Book	6.9	8.6	·	4.4	2.7	4.6	·	3.3	4.7	5.9	·	3.8	3.6	1.9	·	1.6
P / Cash Flow	·	-20.6	·	·	·	-25.0	·	·	·	-36.1	·	·	·	-18.8	·	·
EV / Revenue	2.1	4.0	·	3.1	2.0	5.0	·	3.4	4.9	8.1	·	7.0	7.9	3.9	·	·
Earnings Yield	-38.3%	-21.2%	·	-24.5%	-35.0%	-17.5%	·	-30.8%	-21.4%	-13.6%	·	-13.5%	-13.6%	-22.3%	·	718.4%

Most recent period on the left · null values shown as ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

16

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue	$57M	$51M	$39M	$22M	$13M
Gross Margin %	85.3%	83.8%	84.1%	77.8%	72.1%
Operating Margin %	-90.5%	-116.0%	-109.7%	-189.3%	-199.2%
Net Income	$-53M	$-60M	$-41M	$-41M	$-43M
Diluted EPS	$-2.04	$-2.65	$-1.99	$-2.02	$-4.16

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Debt / Equity	1.3	0.7	0.4	0.1	0.0
Current Ratio	7.6	12.1	14.3	15.2	25.6
Quick Ratio	6.5	10.7	12.5	13.8	24.5

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Free Cash Flow	$-41M	$-41M	$-40M	$-43M	$-29M

Institutional owners (13F) 95 filers · $87.3M total · As of June 30, 2026

17

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Holders 95

Value held $87.3M

New positions 8

Exited positions 18

Institutional activity — Q2 2026 vs prior quarter

New positions	Exited positions	Increased	Decreased	Net shares change
8 (-19 vs prior Q)	18 (+5 vs prior Q)	35 (+2 vs prior Q)	29 (+9 vs prior Q)	+574K

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution	Value	Shares	% of tracked 13F	Type
JOHNSON & JOHNSON	$20,687,786	4,024,861	23.70%	Shares
NEA Management Company, LLC	$10,045,822	1,954,440	11.51%	Shares
VANGUARD GROUP INC	$7,956,707	1,120,663	9.12%	Shares
BlackRock, Inc.	$6,401,661	1,245,459	7.33%	Shares
ROYAL BANK OF CANADA	$6,338,000	1,233,212	7.26%	Shares
GSK plc	$5,178,977	1,007,583	5.93%	Shares
VANGUARD CAPITAL MANAGEMENT LLC	$4,680,361	910,576	5.36%	Shares
SILVERCREST ASSET MANAGEMENT GROUP LLC	$4,513,480	878,109	5.17%	Shares
GEODE CAPITAL MANAGEMENT, LLC	$2,266,478	440,786	2.60%	Shares
PFM Health Sciences, LP	$1,899,600	369,572	2.18%	Shares
STATE STREET CORP	$1,883,049	366,352	2.16%	Shares
RENAISSANCE TECHNOLOGIES LLC	$1,182,200	230,000	1.35%	Shares
UBS Group AG	$1,152,558	224,233	1.32%	Shares
TUDOR INVESTMENT CORP ET AL	$1,057,216	205,684	1.21%	Shares
GOLDMAN SACHS GROUP INC	$768,476	149,509	0.88%	Shares
MORGAN STANLEY	$745,182	144,977	0.85%	Shares
Kestra Advisory Services, LLC	$680,536	132,400	0.78%	Shares
TWO SIGMA INVESTMENTS, LP	$680,526	132,398	0.78%	Shares
VANGUARD FIDUCIARY TRUST CO	$662,829	128,955	0.76%	Shares
DIMENSIONAL FUND ADVISORS LP	$659,866	127,971	0.76%	Shares
NORTHERN TRUST CORP	$641,302	124,767	0.73%	Shares
VANGUARD PORTFOLIO MANAGEMENT LLC	$544,403	105,915	0.62%	Shares
AQR CAPITAL MANAGEMENT LLC	$542,856	105,614	0.62%	Shares
Cresset Asset Management, LLC	$533,784	103,849	0.61%	Shares
AlphaQuest LLC	$502,645	70,795	0.58%	Shares
BNP PARIBAS FINANCIAL MARKETS	$500,168	97,309	0.57%	Shares
Quantinno Capital Management LP	$423,192	82,333	0.48%	Shares
CITADEL ADVISORS LLC	$406,127	79,013	0.47%	Shares
Jump Financial, LLC	$398,350	77,500	0.46%	Shares
Nuveen, LLC	$254,666	49,546	0.29%	Shares
WOLVERINE TRADING, LLC	$228,312	29,346	0.26%	Shares
ALLIANCEBERNSTEIN L.P.	$220,986	23,360	0.25%	Shares
BRIDGEWAY CAPITAL MANAGEMENT, LLC	$210,226	40,900	0.24%	Shares
Bank of New York Mellon Corp	$198,641	38,646	0.23%	Shares
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$181,946	35,398	0.21%	Shares
Point72 Asset Management, L.P.	$137,613	26,773	0.16%	Shares
XTX Topco Ltd	$112,181	21,825	0.13%	Shares
JPMORGAN CHASE & CO	$109,932	18,507	0.13%	Shares
Jain Global LLC	$109,482	21,300	0.13%	Shares
Mitsubishi UFJ Asset Management Co., Ltd.	$106,532	20,726	0.12%	Shares
RBF Capital, LLC	$102,800	20,000	0.12%	Shares
BANK OF AMERICA CORP /DE/	$102,085	19,861	0.12%	Shares
RHUMBLINE ADVISERS	$96,688	18,812	0.11%	Shares
WELLS FARGO & COMPANY/MN	$85,797	16,692	0.10%	Shares
Corton Capital Inc.	$85,461	10,590	0.10%	Shares
MILLENNIUM MANAGEMENT LLC	$84,476	16,435	0.10%	Shares
Graham Capital Management, L.P.	$76,884	14,958	0.09%	Shares
CWM, LLC	$76,238	8,059	0.09%	Shares
JANE STREET GROUP, LLC	$69,390	13,500	0.08%	Call option
R Squared Ltd	$68,907	13,406	0.08%	Shares

Show all 95 institutional owners →

Activists & 5%+ owners 4 positions

18

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer	Filed	Stake	Status	Purpose	Filing
Chernett Jorey ×2 filings	Oct. 2, 2026	0.62%	Amendment	·	SEC
New Enterprise Associates 10, Limited Partnership, New Enterprise Associates 8A, Limited Partnership, NEA Partners 10, Limited Partnership, New Enterprise Associates VIII, Limited Partnership, NEA Partners VIII, Limited Partnership, Anthony A. Florence, Jr., Mohamad H. Makhzoumi, Scott D. Sandell	Feb. 20, 2025	7.80%	Amendment	·	SEC
Cooperatieve Gilde Healthcare IV U.A., Gilde Healthcare IV Management B.V., Gilde Healthcare Holding B.V., Manapouri B.V., Martemanshurk B.V. ×4 filings	Feb. 6, 2025	4.90%	Amendment	·	SEC
New Enterprise Associates 8A, Limited Partnership, New Enterprise Associates 10, Limited Partnership, NEA Partners 10, Limited Partnership, New Enterprise Associates VIII, Limited Partnership, NEA Partners VIII, Limited Partnership, Anthony A. Florence, Jr., Mohamad H. Makhzoumi, Scott D. Sandell ×2 filings	Nov. 7, 2024	·	Initial filing	·	SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Company insiders 25 insiders · 11 officers · 9 directors

19

Insider	Role	Last activity	Shares owned	Buys 12m	Sells 12m	Net 12m
Kevin Hykes	PRES & CEO	Feb. 27, 2026 A	284,237	0	1	$-61,328
Nadim Yared	CHIEF EXECUTIVE OFFICER	Feb. 2, 2024 A	26,255	0	0	$0
Jared Oasheim	CHIEF FINANCIAL OFFICER	Feb. 27, 2026 A	96,703	0	1	$-13,778
Brent Binkowski	CHIEF OPERATING OFFICER	Aug. 13, 2026 P	56,514	1	1	$72,971
Philip B. Adamson	Chief Medical Officer	Feb. 27, 2026 A	61,578	0	1	$-9,970
Robert Allen John	Chief Revenue Officer	Feb. 27, 2026 A	86,036	0	1	$-31,316
Paul Verrastro	CHIEF MKTG & STRAT OFFICER	Feb. 27, 2026 A	60,551	0	1	$-10,144
Craig E. Palmer	SVP, U.S. SALES	March 25, 2024 M	1,229	0	0	$0
Liz Galle	VP OF GLOBAL CLINICAL RESEARCH	Oct. 16, 2023 M	778	0	0	$0
Dean Bruhn-Ding	VP OF REG. AFFAIRS AND QA	Aug. 2, 2022 A	54,648	0	0	$0
John Brintnall	CHIEF STRATEGY OFFICER AND SEC	April 22, 2022 M	21,901	0	0	$0
Martha Shadan	Director	June 1, 2026 A	8,720	0	0	$0
Mitch C. Hill,	Director	June 1, 2026 A	8,720	0	0	$0
Mudit K. Jain	Director	June 1, 2026 A	14,370	2	0	$300,432
Kevin J. Ballinger	Director	June 1, 2026 A	8,720	0	0	$0
Kirk Nielsen	Director	June 1, 2026 A	8,720	0	0	$0
Ali Behbahani	Director	June 4, 2024 A	316	0	0	$0
John M Nehra	Director	June 7, 2022 A	28,266	0	0	$0
Johnson & Johnson Innovation - JJDC, Inc.	10% owner	Sept. 15, 2023 J	0	0	0	$0
New Enterprise Associates 10, Limited Partnership	10% owner	July 2, 2021 C	2,026,083	0	0	$0
Joseph P Slattery	·	June 1, 2026 A	39,365	0	0	$0
DALE MICHAEL D	·	June 1, 2026 A	29,005	0	0	$0
Gregory Morrison	·	March 2, 2026 A	34,000	0	0	$0
Geoffrey B Pardo	·	July 2, 2021 C	1,829,022	0	0	$0
GSK plc	·	July 2, 2021 C	1,007,583	0	0	$0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

ETF ownership Held by 14 ETFs

20

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund	Weight	Units	As of	Source
IWC · iShares Trust	0.01%	51,258 SH	Sept. 11, 2026	Daily
IWO · iShares Trust	0.00%	156,004 SH	Sept. 11, 2026	Daily
RSSL · Global X Funds	0.00%	7,352 NS	July 31, 2026	N-PORT
IWM · iShares Trust	0.00%	364,840 SH	Sept. 11, 2026	Daily
DFAS · Dimensional ETF Trust	0.00%	28,363 NS	July 31, 2026	N-PORT
DCOR · Dimensional ETF Trust	0.00%	1,354 NS	July 31, 2026	N-PORT
IWV · iShares Trust	0.00%	5,299 SH	Sept. 3, 2026	Daily
DFAC · Dimensional ETF Trust	0.00%	5,367 NS	July 31, 2026	N-PORT
VXF · VANGUARD INDEX FUNDS	0.00%	204,533 SH	Aug. 19, 2026	Daily
VTI · VANGUARD INDEX FUNDS	0.00%	684,121 SH	Aug. 19, 2026	Daily
VTWO · VANGUARD SCOTTSDALE FUNDS	0.00%	89,003 SH	Aug. 19, 2026	Daily
VTWG · VANGUARD SCOTTSDALE FUNDS	0.00%	15,722 SH	Aug. 19, 2026	Daily
VTHR · VANGUARD SCOTTSDALE FUNDS	0.00%	1,190 SH	Aug. 19, 2026	Daily
DXUV · Dimensional ETF Trust	0.00%	4 NS	July 31, 2026	N-PORT

CVRX Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

21

rating · 13 analysts BUY

Median target $4.50 +190.3%

3 23.1% Strong Buy

6 46.2% Buy

3 23.1% Hold

1 7.7% Sell

0 0.0% Strong Sell

12-Month Price Target

6 analysts · 2026-10-03

Mean target $4.58 +195.7%

← Below all targets Current price $1.55

Low$3.50 Mean$4.58 High$6.00

Peer comparison (GICS sub-industry) Key metrics vs sector peers

22

FY basis, prices as of each company's last fiscal year-end close.

Ticker	Market Cap	P/E	Rev YoY	Net Margin	ROE	Gross Margin
CVRX	$187M	-3.5	10.4%	-94.1%	-109.6%	85.3%
MDAI	·	·	·	·	·	·
ODYS	$54M	-3.1	-23.9%	-565.0%	-58.7%	28.9%
SRTS	$66M	-8.5	-34.3%	-28.1%	-15.4%	43.2%
POCI	$56M	-11.9	65.2%	-11.5%	-24.5%	17.2%
SNWV	$256M	72.8	35.0%	26.8%	-395.5%	77.1%
QTI	$73M	-3.0	287.9%	-111.4%	-688.9%	45.4%
ARAY	$31M	-0.9	-12.3%	-12.2%	-103.4%	27.7%

My Metrics Your personal watchlist — selected rows from Full Fundamentals

26

Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

CVRX CVRx, Inc. - Common Stock

CVRX Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

CVRX Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

About CVRx, Inc. - Common Stock Company overview from Wikipedia

10-Year Performance Revenue, net income, margins and EPS trends

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Financial Health Debt, liquidity, solvency — balance sheet strength

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

Institutional owners (13F) 95 filers · $87.3M total · As of June 30, 2026

Activists & 5%+ owners 4 positions

Company insiders 25 insiders · 11 officers · 9 directors

ETF ownership Held by 14 ETFs

CVRX Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

12-Month Price Target

Peer comparison (GICS sub-industry) Key metrics vs sector peers

My Metrics Your personal watchlist — selected rows from Full Fundamentals